siteLogo
U M DONATE

The Termeer Foundation Announces Open Nominations for Class of 2022 Termeer Fellows

Dec 14, 2021

Since 2018, Foundation has identified and supported the biotechnology industry’s future leaders and entrepreneurs; seeks the latest Class of Termeer Fellows to join the ranks of emerging biotech executives

CAMBRIDGE, Mass., (December 14, 2021) – The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced that nominations for the class of 2022 Henri Termeer Fellowship are being accepted and opened its application process. The application process will close on February 15th, 2022.

The Henri Termeer Fellowship is awarded each year to up-and-coming company founders, CEOs or heads of life science organizations who are committed to developing medicines and medical technologies that have the potential to deliver life-changing treatments to patients. Recipients are often early in their leadership career trajectory, such as first-time CEOs or senior company executives, and understand the value of establishing professional relationships and community networks that will help foster their own professional growth. Termeer Fellows place a high priority on learning from others and serving as mentors to those individuals in a similar position. Future biotechnology leaders who qualify and are selected as a Termeer Fellow will receive membership in The Henri Termeer Network, an ever-expanding group of emerging and established healthcare leaders who pool their collective experience to advance cures. Additional Fellowship benefits include quarterly mentor presentations, monthly peer-to-peer learning opportunities, individual 1:1 mentoring, and access to other industry events and initiatives sponsored by The Termeer Foundation.

“Since its inception in 2018, The Henri Termeer Fellowship Program has quickly become the hallmark of the Foundation. The extraordinarily talented individuals that we have supported with this initiative continue to evolve along with the companies that they lead,” said Catharine Smith, Executive Director, The Termeer Foundation. “The program identifies and supports emerging leaders who are among the best and brightest in the biotechnology sector. The Foundation is committed to helping companies develop medicines that may someday lead to cures and recognizing the ongoing investment it takes to nurture tomorrow’s leaders who may help in reaching these ground-breaking treatments.”

All applicants for the Henri Termeer Fellows Class of 2022 must complete an online application by February 1, 2022 that can found here. Notifications of acceptance will be sent in April 2022.

Potential Fellows are reviewed by The Termeer Foundation Board of Directors and a rotating group of mentor volunteers. Applicants will offer information that includes: Professional background and accomplishments, academic milestones, professional designations, plus a personal video essay endorsing their selection. Notifications on acceptance and non-acceptance will be sent out in April 2022. The Termeer Foundation is committed to ensuring the inclusiveness of its Fellowship program, particularly in recognition of the underrepresentation of women and Black, Brown and Indigenous People of Color at the CEO level within the biopharmaceutical industry.

“The level of access and support I’ve received from the Termeer Fellowship has been amazing,” said Tina Liu, CEO & Co-founder of Skylark Bio. “The Board, mentors, guest speakers, and peer Fellows are all personally, deeply familiar with the unique challenges of building a biotech company. It’s a fantastic community to go to for help, not to mention perspective and inspiration.”

 

About The Termeer Foundation

The Termeer Foundation is a nonprofit organization working to connect the world of healthcare innovators until every patient has a cure. We build and support an ever-expanding network of biotech entrepreneurs, CEOs, academics, and other innovators because we believe that helping people succeed will ultimately help their innovations reach patients. Our support includes mentoring, networking, professional development, and financial grants intended to facilitate connections, break down silos, strengthen skillsets and ultimately enable a diverse array of current and future healthcare leaders who bring much-needed solutions to patients. Find out more about The Termeer Foundation and how you can support, engage with, and join our network at www.termeerfoundation.org or on LinkedIn @TermeerFoundation.

Contact:
Erica Mawby-Roche
Termeer Foundation
erica@termeerfoundation.org

Termeer Institute Announces 2026 Transatlantic Connections Award Honorees

Shana Wang of PathCision Medicine and Arno Bisschop of Genewity Named as This Year's Recipients

The Termeer Institute today announced the recipients of the 2026 Transatlantic Connections Award (TAC), recognizing two life sciences entrepreneurs — one in the United States and one in the Netherlands — whose work has the potential to strengthen the relationship and thought partnership between the two regions’ life sciences communities.

This year’s honorees are Shana Wang, co-founder and CEO of PathCision Medicine (United States), and Arno Bisschop, CEO of Genewity (Netherlands). Both honorees join the Class of 2026 Termeer Fellows and become members of the Termeer network. Each will receive support to travel to and engage with the life sciences community in the other’s region.

The Transatlantic Connections Award was established in 2021 with support from the Termeer Institute and Health-Holland, and is rooted in the Massachusetts–Netherlands life sciences partnership formalized through a 2019 memorandum of understanding between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy.

“Scientific discovery knows no borders, and the Transatlantic Connections Award reflects that belief,” said Catharine Smith, CEO of the Termeer Institute. “Shana and Arno each bring deep expertise and a patient-first orientation to their work. We look forward to seeing the connections they build as members of the Termeer network and the exchange of ideas that will follow.”

Shana Wang, Co-Founder and CEO, PathCision Medicine

Shana Wang, co-founder and CEO of PathCision Medicine, brings a background in analytics, strategy and operational leadership to her work in life sciences. Prior to founding PathCision, she served as head of marketing and analytics at a femtech company, where she led cross-functional teams to launch new products and implemented data-driven strategies to support market growth. Earlier in her career, she worked in strategy and analytics consulting, advising Fortune 500 companies and developing predictive models to support data-informed decisions. She holds an M.A. in computational and applied mathematics from Rice University and a B.A. in economics and English from Wellesley College.

“Being named a Transatlantic Connections Award honoree is an extraordinary opportunity to learn from and contribute to a community of leaders united by a commitment to patients,” said Shana Wang, co-founder and CEO of PathCision Medicine. “I look forward to building connections across the Atlantic and bringing those perspectives to the work we are doing.”

Arno Bisschop, CEO, Genewity

Arno Bisschop is a medical doctor and entrepreneur in health and life sciences. Trained at the Amsterdam University Medical Center, he holds a PhD in orthopedic and neurosurgery and a master’s degree in management and policy in health and life sciences. Over the past decade, Bisschop has co-founded and exited several health care companies. He currently serves as CEO of Genewity, a clinical-stage company developing gene therapies for patients around the world.

“I am honored to receive the Transatlantic Connections Award and to join the Termeer Fellows community,” said Arno Bisschop, CEO of Genewity. “Collaboration across regions is essential to advancing the science and solutions that patients need, and I look forward to building those connections.”

Wang and Bisschop join a Termeer network that includes more than 600 life science industry leaders— mentors, advisors, board members and community partners — spanning nine countries and united by a shared commitment to patient-centered innovation. Fellows across the program’s history have collectively raised $3.45 billion in funding, with 73% remaining in their roles as CEOs and 87% of their companies continuing to advance. The exchange of ideas and experiences across borders is central to how the Institute drives progress, with the ultimate goal that every patient has a cure.

About the Transatlantic Connections Award 

The Transatlantic Connections Award recognizes one U.S.-based and one Netherlands-based life sciences entrepreneur annually. Honorees become members of the Termeer Fellows class and the broader Termeer network, and receive support to engage with the life sciences community in the other’s region. The award was established in 2021 with support from the Termeer Institute and Health-Holland.

About the Termeer Institute 

The Termeer Institute supports and empowers brilliant life science innovators through values-driven leadership programming, including mentorship, network development and thought leadership to advance groundbreaking, patient-centric solutions. Learn more at termeerinstitute.org.